Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide

British Journal of Dermatology

Volumn 134, Issue 5, 1996, Pages 931-933

  Itoh, T ^a   Hosokawa, H ^a   Shirai, Y ^b   Horio, T ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Shirai Skin Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; PREDNISOLONE; TETRACYCLINE;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; HALLUCINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; ORAL DRUG ADMINISTRATION; PEMPHIGOID; PRIORITY JOURNAL;

EID: 0030010273     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06329.x     Document Type: Article

References (23)

1. Sams WM, Gammon WR. Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol 1982; 6: 431-49.
2. Thomas I, Khorenian S, Albesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993; 28: 74-7.
3. Person JR, Rogers RS. Bullous pemphigoid responding to sulfapyridine and sulfones. Arch Dermatol 1977; 113: 610-5.
4. Greaves MW, Burton JL, Marks J. Azathioprine in the treatment of bullous pemphigoid. Br Med J 1971; 1: 144-5.
5. Milligan A, Hutchinson PE. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol 1990; 22: 796-801.
6. Thivolet J, Barthelemy H, Rigot-Muller G et al. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet 1985; i: 334-5.
7. Krain LS, Landav JW, Newcomer VD. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1972; 106: 657-61.
8. Steinberg AD, Plotz PH, Wolff SM et al. Cytotoxic drugs in treatment of nonmalignant disease. Ann Intern Med 1972; 76: 619-42.
9. Bast RC. Principles of cancer biology: tumor immunology. In Cancer: Principles and Practice of Oncology (De Vita VT, Hellman S, Rosenberg SA, eds). Philadelphia: JB Lippincott, 1985; 142-8.
10. Carette S, Klippel JH, Decker JL et al. Controlled studies of oral immunosuppressive drugs in lupus nephritis: a long-term follow-up. Ann Intern Med 1983; 99: 1-8.
11. McDonald CJ. Cytotoxic agents for use in dermatology I. J Am Acad Dermatol 1985; 12: 753-75.
12. Gilchrist DM, Friedman JM. Teratogenesis and IV cyclophosphamide. J Rheumatol 1989; 16: 1008.
13. Ahmed AR, Hombal SM. Cyclophosphamide. J Am Acad Dermatol 1984; 11: 1115-26.
14. Dinant HJ, Decker JL, Klippel JH et al. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 1982; 96: 728-36.
15. Shibasaki T, Matsumoto H, Ohno I et al. Effect of cyclophosphamide pulse therapy in a patient with intractable lupus nephritis. Jpn J Med 1990; 29: 414-6.
16. Moriuchi J, Ichikawa Y, Tanaka M et al. A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy. Rhyumachi 1989; 29: 291-6.
17. McCune WJ, Golbus J, Zeldes W et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318: 1423-31.
18. Haubitz M, Frei U, Rother U et al. Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transpl 1991; 6: 531-5.
19. Pandya AG, Sontheimer RD. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol 1992; 128: 1626-30.
20. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990; 29: 371-4.
21. Pasricha JS, Thanzama J, Khan UK. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988; 119: 73-7.
22. Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide therapy for the treatment of pemphigus vulgaris. Int J Dermatol 1992; 31: 875-7.
23. Euler HH, Löffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol 1987; 123: 1205-10.